{"schema_version":"secwatch.filing_event.v1","accession":"0001731122-24-000877","form_type":"8-K","ticker":"LNAI","cik":"0001527728","company_name":"Lunai Bioworks Inc.","filed_at":"2024-05-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.846445+00:00","generated_at":"2026-06-01T08:41:41.251971+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Renovaro signs MoU with Amsterdam UMC to form joint cancer immunotherapy company","bullets":["Signed MoU to establish Newco in Netherlands for personalized cancer immunotherapy.","Combines Renovaro's proprietary dendritic vaccine tech with Amsterdam UMC's immunomodulatory expertise.","Newco to be headquartered in Amsterdam; clinical activities may move there.","Final commitments subject to due diligence and approval from both executive boards.","No financial terms or deal value disclosed in the press release."],"urls":{"canonical":"https://secwatch.observer/filing/0001731122-24-000877","json":"https://secwatch.observer/filing/0001731122-24-000877.json","markdown":"https://secwatch.observer/filing/0001731122-24-000877.md","text":"https://secwatch.observer/filing/0001731122-24-000877.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1527728/000173112224000877/0001731122-24-000877-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1527728/000173112224000877/e5707_8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T08:41:41.251971+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}